The newly identified regions in the human genome associated with the disease improve our model of how MS develops. “All four genes are important for regulatory processes within immune cells. Interestingly, they are linked to epigenetic mechanisms. These are bookmarks in the genome that are placed by environmental influences and control the expression of genes”, explains Prof. Dr. Bernhard Hemmer, Director of the Clinic and Policlinic for Neurology at TUM’s Klinikum rechts der Isar and Spokesman of the Executive Board of the KKNMS.
Epigenetic signals mark DNA sequences in human cells and are critical for regulating which of the approximately 20,000 genes inside a cell get activated. These signals are programmed by environmental influences throughout a person’s lifetime. One of the genes identified, named SHMT1, plays a central role in DNA methylation, one of the most important epigenetic regulatory mechanisms.
"Environmental factors strongly contribute to the disease"
The findings expand our understanding of the extent to which genetic influences play a part in the development of MS: “Because the hereditary component in developing MS is limited, environmental factors strongly contribute to the disease. They can influence the activity of MS-relevant genes via epigenetic mechanisms. We have now discovered indicators for regulation of methylation being a potential interface where genetic and environmental MS risk factors interact”, says Prof. Dr. Bertram Müller-Myhsok, Research Group Leader Statistical Genetics at the Max Planck Institute of Psychiatry.
The largest genetic MS study carried out in a single country
Not only did the scientists identify four new risk genes in the German population, but they also confirmed the existence of a dozen previously identified genes. In contrast to earlier studies, they took a new methodological approach: instead of examining a large number of international samples from different ethnic groups, the scientists focused on a single population of genetically homogeneous German patients. This allowed them to identify risk genes that had so far not been discovered in international studies. With just under 5,000 patients and a sample of over 10,000 healthy people, this is the largest genetic MS study carried out in a single country to date. The study has been published in the current edition of the journal Science Advances.
Multiple Sclerosis is an inflammatory disease of the central nervous system. With about 200,000 people affected in Germany alone, it is one of the most common neurological diseases among young adults. In the majority of cases, MS is a relapsing-remitting disease that causes a wide range of symptoms, including visual disturbances, paralysis, numbness, and dizziness. Its cause remains unknown.
Lisa Meier (Press Officer KKNMS)
Tel.: +49 89 4140-7973
Fax: +49 89 4140-4655
T.F.M. Andlauer et al., Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation, Science Advances 2016;2:e1501678 17 June 2016. DOI: 10.1126/sciadv.1501678
The disease-oriented Competence Network Multiple Sclerosis (KKNMS)
The disease-oriented Competence Network Multiple Sclerosis (KKNMS) is one of 21 medical competence networks across Germany initiated by the Federal Ministry for Education and Research. All of them have a single goal: to bring together researchers and scientists from all over Germany and from all disciplines in order to enable the rapid transfer of research findings into practice. The focus of current KKNMS projects is to improve MS diagnosis, treatment and care in the long run. The head office of the network is located at TUM’s Klinikum Rechts der Isar. www.kompetenznetz-multiplesklerose.de
Max Planck InstitutE fOr Psychiatry
The main goal of the Max Planck Institute of Psychiatry is to uphold a uniquely close interaction between basic science, clinical research and clinical services in order to gain knowledge about and understanding of the causes of psychiatric disorders. This knowledge can then be applied in the development of novel diagnostic possibilities as well as therapeutic and preventive approaches. Stress- and trauma-related disorders, such as major depression, posttraumatic stress disorder, and anxiety disorders are our main research and clinical focus. The non-profit research organization can be found in Munich. It consists of five wards with a total 120 beds and an additional capacity of 34 day-clinic spaces amounting to around 2,000 day patients per year. The clinic, the day-clinic and the numerous outpatient clinics allow for an integrated treatment response and a fast and seamless transition from outpatient care to day patient or inpatient care and vice versa. http://www.psych.mpg.de